Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07680478 · ClinicalTrials.gov registry record · Phase 4
Nutrition Intervention Combined With Resmetirom for MASH
A Phase 4 study, sponsored by City University of New York.
- Not yet
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT07680478 is a Phase 4 study that has not yet begun recruiting, run by City University of New York. The registered enrollment target is 120 participants.
The verdict
NCT07680478, a Phase 4 study, has not yet begun recruiting, sponsored by City University of New York.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
This randomized control trial aims to evaluate the effectiveness of combining resmetirom therapy (first approved pharmacological therapy for treating metabolic dysfunction-associated steatohepatitis (MASH)) with a nutritional intervention compared to resmetirom therapy alone over one year in improving liver health among 120 patients living with non-cirrhotic MASH. We hypothesize that patients receiving resmetirom and nutritional intervention will experience more significant improvements in liver function than those receiving only resmetirom therapy.
Interventions
- DRUG Resmetirom therapy
- BEHAVIORAL Comprehensive nutritional intervention
- BEHAVIORAL Standard dietary support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2028-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07680478
The ClinicalTrials.gov registry entry for NCT07680478 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City University of New York, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Resmetirom therapy is the first listed.
NCT07680478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07680478 about?
NCT07680478 is a clinical study titled "Nutrition Intervention Combined With Resmetirom for MASH". This randomized control trial aims to evaluate the effectiveness of combining resmetirom therapy (first approved pharmacological therapy for treating metabolic dysfunction-associated steatohepatitis (MASH)) with a nutritional intervention compared to resmetirom therapy alone over one year in improvi...
What is the current status of trial NCT07680478?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2026-10-01. Estimated completion is 2028-06-30.
What interventions are being tested in trial NCT07680478?
The interventions under investigation include: Resmetirom therapy (DRUG), Comprehensive nutritional intervention (BEHAVIORAL), Standard dietary support (BEHAVIORAL).
Who is sponsoring clinical trial NCT07680478?
This trial is sponsored by City University of New York, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.